Found 10 matching trials
Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Fuzheng Huayu and Entecavir PHASE4 Portal hypertension is a common pathology in chronic liver disease, particu...
Show More Learn More & Join Trial
Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir PHASE4 Liver Cirrhosis is a common pathological consequence of chronic liver disea...
Show More Location
Guangxi Ruikang Hospital
Learn More & Join Trial
Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis PHASE4 The primary purpose of the trial is adopted Fuzheng Huayu tablets against p...
Show More Location
Shuguang Hospital
Learn More & Join Trial
Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis PHASE2 Current treatment of chronic liver disease relies upon removing the primary...
Show More Location
SCTI Research Foundation
Learn More & Join Trial
Fuzheng Huayu Tablets Reduce the Occurrence of Re-Decompensation Events in Patients With First Decompensation of Hepatitis B-Related Liver Cirrhosis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study NA This study aims to conduct a prospective, multicenter, double-blind, random...
Show More Location
Multiple Locations
Learn More & Join Trial
Effects of Fuzheng Huayu Tablets on COVID-19 PHASE4 The 2019 novel coronavirus (2019-nCoV) infection caused clusters of severe ...
Show More Location
Shuguang Hospital
Learn More & Join Trial
Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV PHASE4 Liver Cirrhosis is a common pathological consequence of chronic liver disea...
Show More Location
Guangxi Ruikang Hospital
Learn More & Join Trial
Fuzheng Huayu Tablets for Metabolic Dysfunction-Associated Fatty Liver Cirrhosis (Compensated): A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study PHASE4 This is a multicenter, randomized, double-blind, placebo-controlled clinica...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu PHASE2 According to previous studies, viral pneumonia can develop into pulmonary f...
Show More Location
Shuguang Hospital
Learn More & Join Trial
Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir PHASE4 Portal hypertension is a common pathology in chronic liver disease, particu...
Show More Learn More & Join Trial